See the DrugPatentWatch profile for gilenya
Standard Dosing for Gilenya in MS
Gilenya (fingolimod) is taken once daily as a single oral capsule for relapsing forms of multiple sclerosis (MS) in adults and children aged 10 and older. The typical starting dose is 0.5 mg once per day, with titration only if needed for side effects like bradycardia.[1][2]
How Long-Term Treatment Works
Patients continue one dose daily indefinitely, as long as benefits outweigh risks and under physician monitoring. No fixed number of total doses exists—it's ongoing therapy, often for years, with regular blood tests and cardiac checks before and after the first dose.[1][3]
Dose Adjustments and Variations
- 0.25 mg capsules for patients with body weight under 40 kg (about 88 lbs) in children, or adults prone to side effects.
- First dose requires 6-hour observation in a medical setting for heart rate monitoring.
- No loading doses; steady-state levels build over 1-2 months.[2][4]
Why the Once-Daily Schedule?
Fingolimod binds to sphingosine-1-phosphate receptors, trapping lymphocytes in lymph nodes to reduce MS inflammation. Its 7-9 day half-life supports once-daily dosing without gaps.[3]
Switching or Stopping Gilenya
If pausing therapy, restart with observation due to rebound risks like worsened MS activity 2-3 months post-stop. Common switches go to alternatives like Ocrevus (infusion every 6 months) or oral Tecfidera (twice daily).[4][5]
Common Patient Questions on Dosing
Patients often ask about missed doses: take as soon as remembered unless near next dose—never double up. Pregnancy requires stopping 2 months prior due to fetal risks.[1][2]
Sources
[1]: Gilenya Prescribing Information (Novartis)
[2]: FDA Label for Gilenya
[3]: MS Society on Gilenya
[4]: Drugs.com Gilenya Dosing
[5]: DrugPatentWatch: Gilenya Patents